Paving the way for global medical research, the United Nations Commission on Narcotic Drugs voted in December 2020 to remove cannabis from Schedule IV of their drug classification list. Schedule IV also includes dangerous and highly addictive drugs such as heroin and fentanyl. The reclassification, which garnered...

The island that is often known by foreigners as a haven for pot smokers is experiencing a shortage of marijuana due to heavy rains followed by an extended drought. Although still technically illegal, marijuana in Jamaica is typically bountiful and inexpensive due to lax enforcement...

On Monday, February 22, 2021, New Jersey became the fourteenth state to make cannabis legal when Governor Phil Murphy signed three bills into law that decriminalize marijuana and create a pathway for the legal recreational cannabis market. This comes on the heels of a statewide...

With regards to recreational cannabis licensing, the information below is no longer current. Please see our post on the moratorium for recreational cannabis licensing in Oregon.  Oregon was one of the first states to legalize recreational marijuana in 2014, and the first state to legalize marijuana...

For many years, the efficacy of marijuana in treating various ailments went untested in the United States as researchers eschewed the drug due to its controversial legal status. As a result, much of the research on marijuana has been done by foreign nations. The State...

Cultiva Law is proud to announce that four of our attorneys, Aaron Pelley, Ted Bernhard, Veronica Darling and Mio Asami were named in the Top 200 Cannabis Lawyers by the Cannabis Law Journal. In addition, Aaron Pelley and Michael Solomon were both awarded by Super Lawyers...

This article first appeared in Cannabis Now   Taxation’s War on Cannabis A recent U.S. 9th Circuit Court of Appeals case could have a significant impact on the federal taxation of cannabis businesses, in particular IRC §280E issues. By Kenneth Ford Published on February 5, 2021 Harborside, a California cannabis...

Contact Us For A Consultation

Call (888) 896-3313 or fill out the form below: